UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. HIV陰性患者における非結核性抗酸菌感染症の概要 overview of nontuberculous mycobacterial infections in hiv negative patients
2. 小児の皮膚や軟部組織に発症する非結核性抗酸菌症 nontuberculous mycobacterial skin and soft tissue infections in children
3. Mycobacterium kansasiiやそれ以外の一般的ではない非結核性抗酸菌による成人の肺感染症の治療 treatment of lung infection with mycobacterium kansasii and other less common nontuberculous mycobacteria in adults
4. 非結核性抗酸菌感染症の疫学 epidemiology of nontuberculous mycobacterial infections
5. HIV感染患者における非結核性抗酸菌（MACを除く）の概要 overview of nontuberculous mycobacteria excluding mac in hiv infected patients

English Journal

Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Jagielski T1, Minias A2, van Ingen J3, Rastogi N4, Brzostek A2, Żaczek A5, Dziadek J2.
Clinical microbiology reviews.Clin Microbiol Rev.2016 Apr;29(2):239-90. doi: 10.1128/CMR.00055-15.
Molecular typing has revolutionized epidemiological studies of infectious diseases, including those of a mycobacterial etiology. With the advent of fingerprinting techniques, many traditional concepts regarding transmission, infectivity, or pathogenicity of mycobacterial bacilli have been revisited,
PMID 26912567

Emergence of Refractory Otomastoiditis Due to Nontuberculous Mycobacteria: Institutional Experience and Review of the Literature.

Yeh CF1, Tu TY2, Wang MC2, Chu CH2, Huang CY2, Su WJ3, Shiao AS1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.Clin Infect Dis.2016 Mar 15;62(6):739-45. doi: 10.1093/cid/civ1033. Epub 2015 Dec 21.
BACKGROUND: Nontuberculous mycobacteria (NTM) infection has attracted increasing attention in recent years; however, NTM otomastoiditis is extremely rare. Surgery combined with antibiotic therapy is the current mainstay of treatment; however, the reported duration of medication still varies. In this
PMID 26689957

Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies.

Xie YL1, Rosen LB1, Sereti I2, Barber DL3, Chen RY1, Hsu DC2, Qasba SS4, Zerbe CS1, Holland SM1, Browne SK1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.Clin Infect Dis.2016 Mar 15;62(6):770-3. doi: 10.1093/cid/civ995. Epub 2015 Dec 8.
Interferon-gamma (IFNγ) neutralizing autoantibodies are associated with disseminated nontuberculous mycobacterial infections. We report a previously healthy Thai woman with disseminated tuberculosis and high-titer IFNγ-neutralizing autoantibodies, who developed a severe inflammatory reaction durin
PMID 26646678